Prognostic significance of thymidylate synthase activity in bladder carcinoma
Open Access
- 1 August 2001
- Vol. 92 (3) , 510-518
- https://doi.org/10.1002/1097-0142(20010801)92:3<510::aid-cncr1349>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibodyCancer, 1998
- A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significanceCancer, 1998
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnti-Cancer Drugs, 1996
- Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer CellsJapanese Journal of Cancer Research, 1996
- Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.Journal of Clinical Oncology, 1996
- Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.Journal of Clinical Oncology, 1994
- Prophylactic oral UFT therapy for superficial bladder cancerCancer, 1993
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary resultsCancer Chemotherapy and Pharmacology, 1987
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974